Versameb to Present during World Continence Week 2022
Lead therapeutic candidate has the potential to treat Stress Urinary Incontinence Raising awareness of the high unmet medical need of patients Versameb AG (“Versameb”), focused on discovering and developing innovative RNA-based drugs, is pleased to announce that Chief Executive Officer Klaas Zuideveld and Clinical Advisor Prof. Roger Dmochowski will be presenting Versameb’s lead therapeutic candidate, […]